Tampere University licenses drug for Epidermolysis Bullosa to Theravia
Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin ...
Tag: Molecule
New regulates the immune response against parasites
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites. ...
_6e98296023b34dfabc133638c1ef5d32-620x480.jpg "Study reveals how neurons save energy during protein synthesis")
Study reveals how neurons save energy during protein synthesis
Nerve cells have amazing strategies to save energy and still perform the most important of their tasks. Researchers from the ...
New compound shows promise for treating psoriasis with blue light activation
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and ...
New dye offers breakthrough in deep tissue imaging and cancer therapy
Researchers from Tokyo Metropolitan University have developed a new dye that can strongly absorb second near-IR radiation and transform it ...
Plant chemical discovered to prevent biofilm formation
If your teeth have ever felt fuzzy after skipping a brushing, you've encountered biofilm-a slimy bacterial layer that clings to ...
Study unveils NAD's link to aging and disease development
UiB researchers are behind a new discovery that tells us how associated neurodegenerative diseases might develop.In the center of this ...
Pioneering study shows promising results for cognitive treatment in Down syndrome
The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, ...
Muvalaplin shows promise in lowering Lp(a) levels in clinical trial
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
Small Solutions for Big Problems in Drug Discovery and Delivery
Ijeoma Uchegbu, Professor of Pharmaceutical Nanoscience at UCL and Co-Founder and CSO of Nanomerics, gave one of this year's keynote presentations at ...
